𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HLA antigens in malignant melanoma

✍ Scribed by B. Bergholtz; I. Brennhovd; O. Klepp; A. Kaakinen; E. Thorsby


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
215 KB
Volume
39
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Heterogeneous expression of melanoma-ass
✍ Janice N. Cormier; Yasmine M. Hijazi; Andrea Abati; Patricia Fetsch; Maria Betti πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 367 KB πŸ‘ 2 views

MART-1/MelanA and Pmel17/gp100 are melanoma-associated antigens (MAAs) that can be recognized by tumorinfiltrating lymphocytes (TILs) capable of mediating successful adoptive therapy in vivo. Analysis of melanoma cell lines in vitro has demonstrated that heterogeneous antigen expression in the conte

HLA antigens in TΓΌkuna Indians
✍ Luiz F. Jobim; Nayla C. Moura; Ligia B. L. Persolli; Anete Trachtenberg; Roy Wal πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 386 KB
HLA antigens in juvenile arthritis
✍ Øystein FΓΈrre; Jan H. Dobloug; HANS M. HΓΈyeraal; Erik Thorsby πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 285 KB
Hla antigens in whipple's disease
✍ William O. ; Dobbins Iii πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 341 KB
Malignant melanoma in spouses
✍ Matthew J. Mintzis; Agnes P. Berger; Edward Greenwald; Edith Greenwald; Frederic πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 269 KB πŸ‘ 1 views

A study of three married couples where both spouses developed malignant melanoma was undertaken at the New York University-Bellevue Medical Center melanoma registry. An upper bound was calculated for the number of spouses expected to develop melanoma, along with the origin of the disease and its rel

Heterogeneity in expression of human leu
✍ Galen A. Ohnmacht; Francesco M. Marincola πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of huma